Skip to content
drillr.ai
Sign up

TRAW

Traws Pharma, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.55
+1.49%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue2.8M2.8M226.0K226.0K226.0K
Cost of Revenue2.0K—12.0K——
Gross Profit2.8M2.8M214.0K226.0K226.0K
Operating Expenses
R&D Expense17.3M12.1M130.3M11.4M11.4M
SG&A Expense9.5M8.5M12.3M9.1M8.4M
General & Admin Expense9.5M8.5M12.3M9.1M8.4M
Selling & Marketing Expense—————
Other Expenses——(93.0M)——
Total Operating Expenses26.9M20.7M49.6M20.5M19.9M
Cost and Expenses26.9M20.7M49.6M20.5M19.9M
Operating Income (EBIT)(24.1M)(17.9M)(49.3M)(20.3M)(19.6M)
Non-Operating
Interest Income—————
Interest Expense—————
Net Interest Income—————
Other Non-Op Income/Expense159.0K27.0M(117.2M)1.4M663.0K
Non-Operating Income (excl Interest)(61.0K)—117.2M——
EBT (Pre-Tax Income)(23.9M)9.2M(166.5M)(18.9M)(19.0M)
Income Tax Expense—————
Bottom Line
Net Income(23.9M)9.2M(54.7M)(18.9M)(19.0M)
Earnings from Cont. Ops(23.9M)9.2M(166.5M)(18.9M)(19.0M)
Earnings from Discont. Ops—————
Bottom Line Net Income(21.6M)6.9M(54.7M)(18.9M)(19.0M)
Per Share
Basic EPS($9.79)$0.83($35.21)($22.57)($22.68)
Diluted EPS($9.79)$0.82($35.21)($22.57)($22.68)
Revenue Per Share$0.26$0.34$0.15$0.27$0.27
Shares
Basic Shares Outstanding10.6M8.2M1.6M839554836329
Diluted Shares Outstanding10.6M8.4M1.6M839554836329
Profitability Metrics
EBITDA(23.9M)(17.8M)(166.5M)(20.3M)(19.6M)
D&A91.0K61.0K12.0K16.0K14.0K
EBIT(24.0M)(17.9M)(166.5M)(20.3M)(19.6M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026